| Ustekinumab as induction and maintenance therapy for Crohn’s disease BG Feagan, WJ Sandborn, C Gasink, D Jacobstein, Y Lang, JR Friedman, ... New England journal of medicine 375 (20), 1946-1960, 2016 | 1725 | 2016 |
| IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis K Sugimoto, A Ogawa, E Mizoguchi, Y Shimomura, A Andoh, AK Bhan, ... The Journal of clinical investigation 118 (2), 534-544, 2008 | 1247 | 2008 |
| Curcumin prevents and ameliorates trinitrobenzene sulfonic acid–induced colitis in mice K Sugimoto, H Hanai, K Tozawa, T Aoshi, M Uchijima, T Nagata, Y Koide Gastroenterology 123 (6), 1912-1922, 2002 | 324 | 2002 |
| Evidence-based clinical practice guidelines for inflammatory bowel disease 2020 H Nakase, M Uchino, S Shinzaki, M Matsuura, K Matsuoka, T Kobayashi, ... Journal of gastroenterology 56 (6), 489-526, 2021 | 293 | 2021 |
| Curcumin has bright prospects for the treatment of inflammatory bowel disease H Hanai, K Sugimoto Current pharmaceutical design 15 (18), 2087-2094, 2009 | 249 | 2009 |
| Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study H Hanai, F Watanabe, K Takeuchi, T Iida, M Yamada, Y Iwaoka, ... Clinical Gastroenterology and Hepatology 1 (1), 28-35, 2003 | 220 | 2003 |
| Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP 2C19 genotype T Kagami, S Sahara, H Ichikawa, T Uotani, M Yamade, M Sugimoto, ... Alimentary Pharmacology & Therapeutics 43 (10), 1048-1059, 2016 | 211 | 2016 |
| Induced reactivity of intestinal CD4+ T cells with an epithelial cell lectin, galectin-4, contributes to exacerbation of intestinal inflammation A Hokama, E Mizoguchi, K Sugimoto, Y Shimomura, Y Tanaka, ... Immunity 20 (6), 681-693, 2004 | 183 | 2004 |
| The ulcerative colitis endoscopic index of severity more accurately reflects clinical outcomes and long-term prognosis than the Mayo endoscopic score K Ikeya, H Hanai, K Sugimoto, S Osawa, S Kawasaki, T Iida, Y Maruyama, ... Journal of Crohn's and Colitis 10 (3), 286-295, 2016 | 164 | 2016 |
| Role of STAT3 in inflammatory bowel disease K Sugimoto World journal of gastroenterology: WJG 14 (33), 5110, 2008 | 157 | 2008 |
| Regulatory role of B-1 B cells in chronic colitis Y Shimomura, E Mizoguchi, K Sugimoto, R Kibe, Y Benno, A Mizoguchi, ... International immunology 20 (6), 729-737, 2008 | 132 | 2008 |
| Dual therapy with vonoprazan and amoxicillin is as effective as triple therapy with vonoprazan, amoxicillin and clarithromycin for eradication of Helicobacter pylori T Furuta, M Yamade, T Kagami, T Uotani, T Suzuki, T Higuchi, S Tani, ... Digestion 101 (6), 743-751, 1964 | 104 | 1964 |
| M2 polarization of murine peritoneal macrophages induces regulatory cytokine production and suppresses T‐cell proliferation S Oishi, R Takano, S Tamura, S Tani, M Iwaizumi, Y Hamaya, K Takagaki, ... Immunology 149 (3), 320-328, 2016 | 102 | 2016 |
| Twice‐daily dosing of esomeprazole effectively inhibits acid secretion in CYP2C19 rapid metabolisers compared with twice‐daily omeprazole, rabeprazole or lansoprazole S Sahara, M Sugimoto, T Uotani, H Ichikawa, M Yamade, M Iwaizumi, ... Alimentary pharmacology & therapeutics 38 (9), 1129-1137, 2013 | 95 | 2013 |
| Rapid metabolizer genotype of CYP2C19 is a risk factor of being refractory to proton pump inhibitor therapy for reflux esophagitis H Ichikawa, M Sugimoto, K Sugimoto, A Andoh, T Furuta Journal of Gastroenterology and Hepatology 31 (4), 716-726, 2016 | 90 | 2016 |
| Rabeprazole 10 mg qds decreases 24‐h intragastric acidity significantly more than rabeprazole 20 mg bd or 40 mg om, overcoming CYP 2 C 19 genotype M Sugimoto, N Shirai, M Nishino, C Kodaira, T Uotani, M Yamade, ... Alimentary pharmacology & therapeutics 36 (7), 627-634, 2012 | 77 | 2012 |
| Nutritional therapy versus 6-mercaptopurine as maintenance therapy in patients with Crohn's disease H Hanai, T Iida, K Takeuchi, H Arai, O Arai, J Abe, T Tanaka, Y Maruyama, ... Digestive and Liver Disease 44 (8), 649-654, 2012 | 76 | 2012 |
| Evidence for the critical role of interleukin‐12 but not interferon‐γ in the pathogenesis of experimental colitis in mice K Tozawa, H Hanai, K Sugimoto, S Baba, H Sugimura, T Aoshi, ... Journal of gastroenterology and hepatology 18 (5), 578-587, 2003 | 70 | 2003 |
| Inducible IL-12-producing B cells regulate Th2-mediated intestinal inflammation K Sugimoto, A Ogawa, Y Shimomura, K Nagahama, A Mizoguchi, ... Gastroenterology 133 (1), 124-136, 2007 | 68 | 2007 |
| Exacerbating role of γδ T cells in chronic colitis of T-cell receptor α mutant mice M Nanno, Y Kanari, T Naito, N Inoue, T Hisamatsu, H Chinen, K Sugimoto, ... Gastroenterology 134 (2), 481-490, 2008 | 67 | 2008 |
Satoshi TamuraHamamatsu University School of Medicine在 hama-med.ac.jp 的电子邮件经过验证
